Literature DB >> 7922536

Bilateral lesions of the amygdala attenuate analgesia induced by diverse environmental challenges.

R J Fox1, C A Sorenson.   

Abstract

This study was designed to evaluate the role of the amygdala, particularly its central nucleus, in the induction of analgesia elicited by environmental challenges. Rats with large, radiofrequency lesions centered in the central nucleus were found to display significantly attenuated analgesic responses to three different challenges: cat exposure, acute footshock, and re-exposure to an environment associated with footshock. These findings show that the amygdala plays an important role in the elicitation of analgesia by each of the environmental challenges tested. Since the amygdala has been shown to play a critical role in fear, these findings suggest that the analgesia elicited by these challenges involves a substantial fear component. Moreover, the finding that amygdala lesions significantly reduced the analgesia elicited by a non-noxious unconditional stimulus (cat exposure) strongly suggests that these lesions disrupt the expression of analgesia rather than producing a learning impairment. And finally, the findings of this study support the suggestion that fear-elicited analgesia is triggered by activation of a projection from amygdala to periaqueductal gray which forms one component of an integrated 'defensive behavioral system.'

Entities:  

Mesh:

Year:  1994        PMID: 7922536     DOI: 10.1016/0006-8993(94)91120-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing.

Authors:  M Fendt
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment.

Authors:  Michal Bajo; Marisa Roberto; Samuel G Madamba; George Robert Siggins
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

3.  Amygdala and periaqueductal gray lesions only partially attenuate unconditional defensive responses in rats exposed to a cat.

Authors:  Beatrice M de Oca; Michael S Fanselow
Journal:  Integr Physiol Behav Sci       Date:  2004 Oct-Dec

4.  Distinct pathways for norepinephrine- and opioid-triggered antinociception from the amygdala.

Authors:  J J Maire; L N Close; M M Heinricher; N R Selden
Journal:  Eur J Pain       Date:  2015-04-05       Impact factor: 3.931

Review 5.  Psychological risk factors in headache.

Authors:  Robert A Nicholson; Timothy T Houle; Jamie L Rhudy; Peter J Norton
Journal:  Headache       Date:  2007-03       Impact factor: 5.887

6.  Amygdalar function reflects common individual differences in emotion and pain regulation success.

Authors:  Regina C Lapate; Hyejeen Lee; Tim V Salomons; Carien M van Reekum; Lawrence L Greischar; Richard J Davidson
Journal:  J Cogn Neurosci       Date:  2011-08-23       Impact factor: 3.225

7.  Contribution of amygdala CRF neurons to chronic pain.

Authors:  Matthew Andreoli; Tanvi Marketkar; Eugene Dimitrov
Journal:  Exp Neurol       Date:  2017-08-19       Impact factor: 5.330

8.  Alpha(2)-noradrenergic antagonist administration into the central nucleus of the amygdala blocks stress-induced hypoalgesia in awake behaving rats.

Authors:  J P Ortiz; L N Close; M M Heinricher; N R Selden
Journal:  Neuroscience       Date:  2008-09-03       Impact factor: 3.590

9.  Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear.

Authors:  D L Walker; M Davis
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

10.  Noradrenergic agonist administration into the central nucleus of the amygdala increases the tail-flick latency in lightly anesthetized rats.

Authors:  J P Ortiz; M M Heinricher; N R Selden
Journal:  Neuroscience       Date:  2007-07-12       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.